Nutr Res Pract.  2008 Sep;2(3):152-157.

Effects of soybean supplementation on blood glucose, plasma lipid levels, and erythrocyte antioxidant enzyme activity in type 2 diabetes mellitus patients

• Chang JH
• Kim MS
• Kim TW
• Lee SS

Abstract

The purpose of this study was to investigate the effect of soybean on blood glucose and lipid concentrations, and antioxidant enzyme activity in type 2 diabetes mellitus (DM) patients. We divided patients into two groups and fed them, respectively, a basal diet (control group) and a basal diet with 69 g/d of soybean (soybean group) for 4 weeks. Pills with roasted soybean powder were provided to the soybean supplementation group three times a day. Macronutrients intake except dietary fiber was similar between the two groups. No significant differences were observed in dietary intakes or body weight before and after the supplementation. Energy composition ratio of C:F:P was 65:19:16 in the control group, 64:20:16 in the soybean group. The blood parameters of subjects before supplementation, such as fasting blood glucose, postprandial glucose level, total cholesterol, triglyceride, LDL-cholesterol and HbA1C were not different between the two groups. After supplementation, fasting blood glucose (p<0.001), postprandial glucose level (p<0.001) and serum triglyceride level (p<0.05) were significantly reduced in the soybean group in comparison with the control group. The total cholesterol level was not significantly different between the control and the supplemented group after 4 weeks of treatment. TBARS levels of the soybean group were not significantly different from those of the control group. The activities of catalase (p<0.01) and glutathione peroxidase (p<0.05) were significantly higher in the soybean group compared to the control group. The results of this study suggest that soybean supplementation would be helpful to control blood glucose and serum lipid in diabetic patients. Also, soybean showed an antioxidant activity that may contribute to enhance the effect of antioxidant defense. This activity contributes to protection against oxidative damage in type 2 DM patients. Soybean may have potential use in the disease management of patients with DM.

Keyword

Soybean; glycemic control; blood lipid levels; antioxidant enzyme activities; type 2 DM

MeSH Terms

Blood Glucose
Body Weight
Catalase
Cholesterol
Diabetes Mellitus, Type 2
Diet
Dietary Fiber
Disease Management
Erythrocytes
Fasting
Glucose
Glutathione Peroxidase
Humans
Plasma
Soybeans
Thiobarbituric Acid Reactive Substances
Blood Glucose
Catalase
Cholesterol
Glucose
Glutathione Peroxidase
Thiobarbituric Acid Reactive Substances

Reference

1. Aebi HE. Catalase. Methods of enzymatic analysis. 1984. vol.3. Weinheim. Germany: Verlag Chemie CMBH;273–285.

2. Alan CT, Arthur IV, Grace SL. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagons, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr. 1987. 45:596–601.

3. Anderson JW, Chen W-JL, Sieling B. Hypolipidemic effect of high-carbohydrate, high-fiber diets. Metabolism. 1980. 29:551–558.

4. Anderson JW, Johnsstone BW, Cook-Newell ME. Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995. 333:276–282.

5. Anderson JW, Randles KM, Kendall DW, Jenkins DJ. Carbohydrate and fiber recommendations for individuals with diabetes a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr. 2004. 23:5–17.

6. Chance B, Greenstein DS, Roughton FJ. The mechanism of catalase action 1 - steady state analysis. Arch Biochem. 1952. 37:301–321.

7. Coulston AM, Hollenbeck CB. Source and amount of dietary carbohydrate in patients with noninsulin-dependent diabetes mellitus. Top Clin Nutr. 1988. 3:17–24.

8. Flohe L, Gunzler W. Assays of glutathione peroxidase. Methods in enzymology. 1984. vol.105. New York. USA: Academic Press;114–121.

9. Food and Drug Administration. Food labeling, health claimms, soy proteins, and coronary heart disease. Fed Regist. 1999. 57:699–733.

10. Grace SL, Andrew PG, Angelita L, John JG, Carl A, Gustav S. Soy fiber improves lipid and carbohydrate metabolism in primary hyperlipidemic subjects. Atherosclerosis. 1986. 62:239–248.

11. Hermansen K, Sondergraad M, Hoie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes care. 2001. 24:228–233.

12. Holf S, Heading RC, Carter DC, Prescott LE, Tothill P. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet. 1979. 1:636–639.

13. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autooxidative glycosylation. Glucose autooxidation as the cause of protein damage in the experimental glycation model of diabetes and aging. Biochem J. 1988. 256:205–212.

14. Jenkins DJA, Wolever TMS, Taylor RH. Glycemic index of foods:a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981. 34:362–366.

15. Kang MJ, Kim JI, Yoon SY, Kim JC, Cha IJ. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. J Med Food. 2006. 9:182–186.

16. Kesavulu MM, Rao BK, Giri R, Vijaya J, Subramanyam G, Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetic with coronary heart disease. Diabetes Res Clin Pract. 2001. 53:33–39.

17. Kim EM, Rah MY, Park MS, Baik HJ. Guidelines for clinical nutrition management. 1999. Seoul. Republic of Korea: The Korean Dietetic Association;180–216.

18. Kjeld H, Marius C, Mette S, Birgitte B, Lars H. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care. 2001. 24:228–233.

19. Kumuhekar HM, Katyane SS. Altered kinetic attributes of Na⁺-K⁺ ATPase activity in kidney, brain and erythrocyte membrane in alloxan diabetic rats. Indian J Exp Biol. 1992. 30:26–32.

20. Kurowska EM, Jordan J, Spence JD. Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects. Clin Invest Med. 1997. 20:162–170.

21. Lee JS. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci. 2006. 79:1578–1584.

22. Lee YK, Lee HS, Kim BW. Dietary fiber intake in subject with non-insulin dependent diabetes mellitus. Diabetes. 1994. 1:256–262.

23. Mahoney JJ, Verman HJ, Stevenson DK, Van Vessel AL. Measurements of carboxyhaemoglobin by five spectrophotometers (cooximeters) in comparison with reference methods. Clin Chem. 1993. 39:1693–1700.

24. Marklund S. Pyrogallol autoxidation. CRC handbook of methods for oxygen radical research. 1984. Boca Raton, FL. USA: CRC Press Inc.;243.

25. McColl AJ, Kong C, Nimmo L, Collins J, Elkeles RS, Richmond W. Total antioxidant status, protein glycation, lipid hydroperoxides in non insulin dependent diabetes mellitus. Biochem Soc Trans. 1997. 25:S660.

26. McCord JM, Keele BB, Fridovich I. An enzyme based theory of obligate anaerobiosis : The physiological functions of superoxide dismutase. Proc Natl Acad Sci USA. 1971. 68:1024–1027.

27. Min HK, Huh KB. Clinical characteristics of diabetes in Korea. Diabetes. 1992. 16:163–174.

28. Palanduz S, Ademoglu E, Gokkusu C, Tamer S. Plasma antioxidants and type 2 diabetes mellitus. Res Commun Mol Pathol Pharmacol. 2001. 109:309–318.

29. Polichetti E, Diaconesku N, De La Porte PL, Malli L, Portugal H, Pauli AM. Cholesterol-lowering effect of soybean lecithin in normolipidaemic rats by stimulation of biliary lipid secretion. Br J Nutr. 1996. 75:471–478.

30. Simpson HCR, Simpson RW, Lousley S. A high carbohydrate leguminous fiber diet improves all aspects of diabetic control. Lancet. 1981. 1:1–5.

31. Slameron J, Manson JE, Stampfer MJ, Colditz G, Wing AL, Willett WC. Dietary fiber glycemic load and risk of non-insulin dependent diabetes mellitus in women. JAMA. 1997. 277:472–477.

32. Subramanian V, Leelavinothan P. Antioxidant effect of Phaseolus vulgaris in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2002. 11:206–209.

33. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of diabetes mellitus. N Engl J Med. 1993. 329:977–986.

34. Tonstard S, Smerud K, Hoie L. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr. 2002. 76:78–84.

35. Venkateswaran S, Pari L. Antioxidant effect of Phaseolus vulgaris on streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2002. 11:206–209.

36. Wild S, Roglic G, Green A. Global prevalence of diabetes. Diabetes Care. 2004. 27:1047–1053.

37. Zacharia M. Effect of brown rice and soybean dietary fiber on the control of glucose and lipid metabolism in diabetic rats. Am J Clin Nutr. 1983. 38:388–393.